Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-08

FDA Approved: SILDENAFIL — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for sildenafil citrate (ANI Pharmaceuticals, Inc.) under an approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sildenafil citrate (Sildenafil citrate)

Snippet

SUPPL AP for SILDENAFIL (SILDENAFIL CITRATE)